Why the study?
Does adherence to quality measures and hospital/surgeon volume improve 30-day mortality and readmission in patients undergoing coronary artery bypass surgery?
Does adherence to quality measures and hospital/surgeon volume improve 30-day mortality and readmission in patients undergoing coronary artery bypass surgery?
Maximizing adherence to quality measures during CABG is associated with improved mortality rates, neutralizing the traditional volume-outcome relationship.
Answers are grounded in this paper and cite their sources.
Adherence to aspirin and beta-blocker therapy was associated with reduced CABG mortality independent of volume; leaves open the impact of quality improvement initiatives on outcomes.
BACKGROUND: Care from high-volume centers or surgeons has been associated with lower mortality rates in coronary artery bypass surgery, but how volume and quality of care relate to each other is not well understood. OBJECTIVE: To determine how volume and differences in quality of care influence outcomes after coronary artery bypass surgery. DESIGN: Observational cohort. SETTING: 164 hospitals in the United States. PATIENTS: 81,289 patients 18 years or older who had coronary artery bypass grafting from 1 October 2003 to 1 September 2005. MEASUREMENTS: Hospital and surgeon case volumes were estimated by using a data set. Quality measures were defined by whether patients received specific medications and by counting the number of measures missed. Hierarchical models were used to estimate effects of volume and quality on death and readmission up to 30 days. RESULTS: After adjustment for clinical factors, lowest surgeon volume and highest hospital volume were associated with higher mortality rates and lower readmission risk, respectively. Patients who did not receive aspirin (odds ratio, 1.89 [95% CI, 1.65 to 2.16) or beta-blockers (odds ratio, 1.29 [CI, 1.12 to 1.49]) had higher odds for death, after adjustment for clinical risk factors and case volume. Adjustment for individual quality measures did not alter associations between volume and readmission or death. However, if no quality measures were missed, mortality rates at the lowest-volume centers (adjusted mortality rate, 1.05% [CI, 0.81% to 1.29%]) and highest-volume centers (adjusted mortality rate, 0.98% [CI, 0.72% to 1.25%]) were similar. LIMITATION: Because administrative data were used, the quality measures may not replicate measures collected through chart abstraction. CONCLUSION: Maximizing adherence to quality measures is associated with improved mortality rates, independent of hospital or surgeon volume. PRIMARY FUNDING SOURCE: California HealthCare Foundation.
No takes yet. Share an insight, caveat, or question.
Andrew D. Auerbach (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: